EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Macrophage migration inhibitory factor may contribute to the occurrence of multiple primary lung adenocarcinomas

Wei Liu iD, Hao-Shuai Yang, Fei-Hang Zhi, Yan-Fen Feng, Hong-He Luo, Ying Zhu, Yi-Yan Lei

Clinical and Translational Medicine · 2023

DOI: 10.1002/ctm2.1368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2023. Verfasst von Wei Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Macrophage Migration-Inhibitory Factors, Adenocarcinoma of Lung, Lung Neoplasms, Neoplasms, Multiple Primary. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to identify the key genes involved in the development of multiple primary lung cancers.

Methods

Differential expression analysis was performed, followed by comparing the infiltration levels of 22 immune cell types between multiple and single primary lung adenocarcinomas. Marker genes for epithelial cells with different proportions between the two types of lung adenocarcinomas were identified. The common genes between the marker genes and differentially expressed genes were identified. Finally, the effects of the key genes were tested on the in vitro proliferation, migration and morphology.

Results

The infiltration levels of helper follicular T cells, resting NK cells, activated NK cells, M2 macrophages and resting mast cells were higher in the patients with multiple than in those with single primary lung adenocarcinomas. A total of 1553 differentially expressed genes and 4414 marker genes of epithelial cells were identified. Logistic regression analysis was performed on the 164 resulting genes. The macrophage migration inhibitory factor expression was positively associated with the occurrence of multiple primary lung adenocarcinomas. Moreover, its signalling pathway was the key pathway among the epithelial cells and multiple and single primary lung adenocarcinoma cells, and it was upregulated in lung adenocarcinoma cells. It also increased the expression of lung cancer markers, including NES and CA125, induced morphological changes in alveolar epithelial type II cells, and promoted their proliferation, migration and invasion.

Conclusions

Multiple and single primary lung adenocarcinomas have different tumour immune microenvironments, and migration inhibitory factor may be a key factor in the occurrence of multiple primary lung adenocarcinomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macrophage Migration-Inhibitory FactorsAdenocarcinoma of LungLung NeoplasmsNeoplasms, Multiple PrimaryHumansLungTumor Microenvironment

Substanzen

Macrophage Migration-Inhibitory Factors

Autor:innen und Institutionen

  • Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
  • Department of Thoracic Surgery, China-Japan Friendship Hospital, Beijing, China.
  • State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
  • Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
  • Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

ORCID-Profile: Wei Liu

Zitieren

APA

Liu, W., Yang, H. S., Zhi, F. H., Feng, Y. F., Luo, H. H., Zhu, Y., & Lei, Y. Y. (2023). Macrophage migration inhibitory factor may contribute to the occurrence of multiple primary lung adenocarcinomas. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1368

Vancouver

Liu W, Yang HS, Zhi FH, Feng YF, Luo HH, Zhu Y, et al. Macrophage migration inhibitory factor may contribute to the occurrence of multiple primary lung adenocarcinomas. Clinical and Translational Medicine. 2023. doi:10.1002/ctm2.1368

BibTeX
@article{Liu2023,
  author = {Liu, Wei and Yang, Hao-Shuai and Zhi, Fei-Hang and Feng, Yan-Fen and Luo, Hong-He and Zhu, Ying and Lei, Yi-Yan},
  title = {Macrophage migration inhibitory factor may contribute to the occurrence of multiple primary lung adenocarcinomas},
  journal = {Clinical and Translational Medicine},
  year = {2023},
  doi = {10.1002/ctm2.1368}
}
Kostenlos starten →